Amaanta Healthcare IPO: Today is the last day, how much GMP, should it be applied or not?

[ad_1]

Last update:September 03, 2025, is 11:47

Amaanta Healthcare IPO- Amanta Healthcare Limited was established in December 1994. There is a pharmaceutical company, which is the development, manufacture and market development of different types of sterile liquid products, especially parental products …Read more

Amaanta Healthcare IPO: Today is the last day, how much GMP, should it be applied or not?

New Delhi. Today is the last day to invest money in the IPO of Amanta Healthcare Limited open on Monday. On Wednesday 3 September, this IPO was filled 33.44 times by 11:25 pm. Issu has received 33.37 times in retail category, 0.82 times in QIB and 72.44 times in NII category. In the gray market too, Amanta is trading on the share premium of Healthcare. The outlook of brokerage houses is also positive about this IPO.

The price band of the IPO of this fast growing company in the pharma sector is ₹ 120 to ₹ 126 per share. The company will raise ₹ 126 crore by issuing new shares, so the entire amount will go to strengthen the balance sheet of the company. This issue will be list on both BSE and NSE exchanges. There are 119 shares in a lot. Retail investment will have to bid for at least one lot. In this way, he will have to invest at least Rs 14,994 in this issue.

Company Profile

Amanta Healthcare Limited was founded in December 1994. There is a pharmaceutical company that produces, manufacture and marketing different types of sterile liquid products, especially parentral products. The company also produces medical equipment, fluid medical formulation and iCare products. The revenue of Amanta Healthcare Limited declined by 2% and Profit After Tax (PAT) increased by 189% between the financial year ending on 31 March 2025 and 31 March 2024.

Should you invest money in Amanta Health IPO?

According to a report by Livemint, the company’s plans to increase focus and production capacity on branded and generic products under the Sterryport brand strengthens its growth strategy. The company’s preparation to remove rising demand and supply obstacles further strengthens the trust of investors. According to Scoop Investment, the company’s estimated market captilation on the upper price band of the IPO is ₹ 489 crore.

The amount raised from the IPO will be used in capacity expansion and debate reduction, which is likely to perform the company’s performance in the long term and better. Brokerage has given it a rating of “subscribe to long term”.

(Disclaimer: Investment made in IPO is subject to market risks. If you want to invest in IPO then consult the first certified Investment Advisor. AyraNews24x7 will not be responsible for any kind of profit or loss.)

Click here to add AyraNews24x7 as your favorite news source on Google.

Place :